Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by Jessica Weisman-Pitts
Posted on January 31, 2022
The global central venous catheter market has been estimated to be valued at US$ 647.9 Mn in 2015 and is expected to register a 5.1% CAGR over the forecast period (2016–2026).
Need for minimal invasive surgeries have been increasing since few years as it reduces the possibilities of postoperative complications. This has led to increasing production sales of central venous catheters across the global market. Rapid increase in the number of cancer patients are likely to drive the production sales of central venous catheters for the purpose of completing chemo processes, which the treatment for cancer much easier.
Geriatric population are likely to experience more chronic health conditions, especially chronic kidney diseases, thereby fuelling demand and supply of CVCs. Apart from this, increasing rate of hospitalization and drug administration in the outpatient settings where the patient is in need of IV therapy, stimulates the growth of central venous catheter market.
The National Center for Biotechnology Information is of the point of view that data assessment strategies and quality indicators for the purpose of preventing bloodstream infections with central venous catheter has been developed. Launch of sterile and disposable catheters has unlocked significant growth opportunities for market for central venous catheters as it helps in preventing infections while using catheter Leading players such as AngioDynamics, Inc. has enhanced its Oncology business with the addition of BioScentry technology. This step has been taken as a thoughtful and strategic acquisition, which would help the company in delivering economically favorable, clinically relevant and deliver safer solutions for the improvement of patient outcomes.
A recent study by Future Market Insights envisages that market for central venous catheter has been anticipated to expand at a steady 5.1% CAGR during 2016 to 2026. Inadequate quality check and high-costs with regards to catheters are key challenges limiting growth of market for central venous catheters, especially in the developing regions such as Middle East, Asia-Pacific and Africa. Non-tunneled central venous catheters is likely to hold the lion’s share in market for central venous catheters as it has been highly beneficial during emergency situations for blood withdrawal purposes. Hospitals contribute towards the maximum usage of central venous catheters owing to increased number of surgical care and quality facilities to its patients.
Polyurethanes are now being preferred over silicon for the production of central venous catheters, in light of the material’s relative compatibility and softness. However, multi-lumen catheters have taken the lead in terms of design, as it helps in reducing the frequency of catheter insertion, thereby enabling multiple drugs to get inserted with a single catheter.
North America is likely to dominate market for central venous catheters during the forecast period. The report says that central venous catheter market in the U.S. is the most profitable market in North America as the region has been witnessing increasing number of FDA approvals for the antimicrobial coated catheters. Asia-Pacific will display significant growth opportunities for market for central venous catheters in the forthcoming years on account of rising number of specialized clinics and hospitals in China and India. Rapidly increasing need for innovative medical technologies is expected to strengthen its position as healthcare hub in APEJ.
Key players and manufacturers in market for central venous catheters have been taking immense efforts in product launches with regards to antimicrobial coated catheters, due to increasing cases of infections thereby stimulating the production sales of the product across the globe. The U.S. FDA (Food and Drug Administration) has approved the antimicrobial coated central venous catheters for preventing bloodstream infections related to catheter.
Latest technological innovations have resulted in the interventional surgeons, anesthesiologists and radiologists having access to the technologically improved central venous catheters. As a consequence, tip location devices, which helps in accurate and precise location of the catheter’s tip, are gaining increased momentum.. In addition, there have been innovations such as new catheter material compositions, which helps in improving user’s post and pre-catheterization. Antimicrobial coatings, which help in preventing infections and biocompatible materials such as polymer and silicone mixes that are substituting latex materials, are also witnessing high demand in order to reduce the intensity of pain during administration.
For any queries regarding the research findings, kindly contact Future Market Insights’ analysts at [email protected]
Key Segment
By Product Type
By Property
By Design
By Composition
By End Use
By Region
Explore wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/central-venous-catheter-market
Press Release Source: https://www.futuremarketinsights.com/press-release/central-venous-catheter-market
The global central venous catheter market has been estimated to be valued at US$ 647.9 Mn in 2015 and is expected to register a 5.1% CAGR over the forecast period (2016–2026).
Need for minimal invasive surgeries have been increasing since few years as it reduces the possibilities of postoperative complications. This has led to increasing production sales of central venous catheters across the global market. Rapid increase in the number of cancer patients are likely to drive the production sales of central venous catheters for the purpose of completing chemo processes, which the treatment for cancer much easier.
Geriatric population are likely to experience more chronic health conditions, especially chronic kidney diseases, thereby fuelling demand and supply of CVCs. Apart from this, increasing rate of hospitalization and drug administration in the outpatient settings where the patient is in need of IV therapy, stimulates the growth of central venous catheter market.
The National Center for Biotechnology Information is of the point of view that data assessment strategies and quality indicators for the purpose of preventing bloodstream infections with central venous catheter has been developed. Launch of sterile and disposable catheters has unlocked significant growth opportunities for market for central venous catheters as it helps in preventing infections while using catheter Leading players such as AngioDynamics, Inc. has enhanced its Oncology business with the addition of BioScentry technology. This step has been taken as a thoughtful and strategic acquisition, which would help the company in delivering economically favorable, clinically relevant and deliver safer solutions for the improvement of patient outcomes.
A recent study by Future Market Insights envisages that market for central venous catheter has been anticipated to expand at a steady 5.1% CAGR during 2016 to 2026. Inadequate quality check and high-costs with regards to catheters are key challenges limiting growth of market for central venous catheters, especially in the developing regions such as Middle East, Asia-Pacific and Africa. Non-tunneled central venous catheters is likely to hold the lion’s share in market for central venous catheters as it has been highly beneficial during emergency situations for blood withdrawal purposes. Hospitals contribute towards the maximum usage of central venous catheters owing to increased number of surgical care and quality facilities to its patients.
Polyurethanes are now being preferred over silicon for the production of central venous catheters, in light of the material’s relative compatibility and softness. However, multi-lumen catheters have taken the lead in terms of design, as it helps in reducing the frequency of catheter insertion, thereby enabling multiple drugs to get inserted with a single catheter.
North America is likely to dominate market for central venous catheters during the forecast period. The report says that central venous catheter market in the U.S. is the most profitable market in North America as the region has been witnessing increasing number of FDA approvals for the antimicrobial coated catheters. Asia-Pacific will display significant growth opportunities for market for central venous catheters in the forthcoming years on account of rising number of specialized clinics and hospitals in China and India. Rapidly increasing need for innovative medical technologies is expected to strengthen its position as healthcare hub in APEJ.
Key players and manufacturers in market for central venous catheters have been taking immense efforts in product launches with regards to antimicrobial coated catheters, due to increasing cases of infections thereby stimulating the production sales of the product across the globe. The U.S. FDA (Food and Drug Administration) has approved the antimicrobial coated central venous catheters for preventing bloodstream infections related to catheter.
Latest technological innovations have resulted in the interventional surgeons, anesthesiologists and radiologists having access to the technologically improved central venous catheters. As a consequence, tip location devices, which helps in accurate and precise location of the catheter’s tip, are gaining increased momentum.. In addition, there have been innovations such as new catheter material compositions, which helps in improving user’s post and pre-catheterization. Antimicrobial coatings, which help in preventing infections and biocompatible materials such as polymer and silicone mixes that are substituting latex materials, are also witnessing high demand in order to reduce the intensity of pain during administration.
For any queries regarding the research findings, kindly contact Future Market Insights’ analysts at [email protected]
Key Segment
By Product Type
By Property
By Design
By Composition
By End Use
By Region
Explore wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/central-venous-catheter-market
Press Release Source: https://www.futuremarketinsights.com/press-release/central-venous-catheter-market
